Skip to main content

Table 2 Tpl-2/Cot expression in PBMC

From: Expression of the Tpl2/Cot oncogene in human T-cell neoplasias

Patient no. Tpl2-Norma Fold increase (R)b CV(%)-Rc
Ctr (n = 3) 0.04 ± 0.019 1.00 ± 0.119 45.3
1 0.02 ± 0.000 0.59 ± 0.009 1.6
2 0.13 ± 0.005 3.88 ± 0.149 3.8
3 0.13 ± 0.005 4.04 ± 0.143 3.5
4 0.02 ± 0.003 0.66 ± 0.092 13.9
5 0.04 ± 0.005 1.22 ± 0.092 11.8
6 0.06 ± 0.003 1.70 ± 0.085 5.0
7 0.06 ± 0.002 1.81 ± 0.076 4.2
8 0.17 ± 0.008 5.21 ± 0.251 4.8
9 0.01 ± 0.000 0.32 ± 0.007 2.2
10 0.16 ± 0.006 5.04 ± 0.194 3.8
11 0.04 ± 0.001 1.09 ± 0.037 3.4
12 0.04 ± 0.004 1.22 ± 0.108 8.9
  1. a. Tpl2/Cot normalized to GAPDH by equation (3) in the text ± SD.
  2. b. Tpl2/Cot-Norm (sample) ratio to Tpl2/Cot-Norm (control) by equation (2) in the text ± SD. Samples in which Tpl2/Cot is overexpressed are shown in bold.
  3. c. % Coefficient variance of (R).